Showing 151-160 of 1484 results for "".
- Xylyx Bio's Matrikynes Improves the Structure, Function, and Appearance of Skinhttps://practicaldermatology.com/news/xylyx-bios-matrikynes-improves-the-structure-function-and-appearance-of-skin/2461645/Xylyx Bio’s
- Aditxt, Inc. Successfully Completes Preclinical Toxicity Study of Its Psoriasis Drug Candidate ADI-100https://practicaldermatology.com/news/aditxt-inc-successfully-completes-preclinical-toxicity-study-of-its-psoriasis-drug-candidate-adi-100/2461260/Aditxt, Inc.’s
- Olay Rolls Out The Olay Skin Advisor 2.0https://practicaldermatology.com/news/olay-rolls-out-the-olay-skin-advisor-20/2458270/Olay’s new
- Commentary: Beware Impact of TikTok's Algorithm on Dermatological Information Disseminationhttps://practicaldermatology.com/news/commentary-beware-impact-tiktoks-algorithm-dermatological-information-dissemination/2467491/A recent commentary in The Journal of Drugs in Dermatology exploring concerns about the dissemination of dermatological information on T
- American Skin Association, National Council for Skin Cancer Prevention Partner for Sun Safetyhttps://practicaldermatology.com/news/american-skin-association-national-council-for-skin-cancer-prevention-partner-for-sun-safety/2461745/The American Skin Association has partnered with the National Council on Skin Cancer Prevention and its broad coalition of member organizations to designate May 26. 2023 as "Don't Fry Day." "Don't Fry Day is the perfect way to jump start the summer holi
- Study: Acute Itching in AD Linked to Environmental Triggershttps://practicaldermatology.com/news/study-acute-itching-in-ad-linked-to-environmental-triggers/2460658/Allergens in the environment often are to blame for episodes of acute itch in eczema patients, and that this itching often doesn’t respond to antihistamines because the itch signals are being carried to the brain along a previously unrecognized pathway that current drugs don’t ta
- OPTiM Trial Results: New Immunotherapy Study in Melanomahttps://practicaldermatology.com/news/20130409-optim_trial_results_new_immunotherapy_study_in_melanoma/2459569/Results from the Oncovex (GM-CSF) Pivotal Trial in Melanoma (OPTiM) show that a genetically modified version of herpes simplex virus type 1, designated talimogene laherparepvec (T-VEC), shrank melanoma in patients who were in the late stages of the disease. The T-VEC virus works through direct dest
- Sotyktu Demonstrates Durable Efficacy and Consistent Safety for up to Three Years in Moderate-to-Severe Plaque PsOhttps://practicaldermatology.com/news/sotyktu-demonstrates-durable-efficacy-and-consistent-safety-for-up-to-three-years-in-moderate-to-severe-plaque-pso/2462066/Bristol Myers Squibb’s
- DermaSensor’s Skin Cancer Device May Help Primary Care Providers Spot Skin Cancerhttps://practicaldermatology.com/news/dermasensors-skin-cancer-device-may-help-internists-spot-skin-cancer/2461703/DermaSensor Inc.’s nove
- Score: Droplette Micro-infuser Named one of Time Magazine's Best Inventions of 2022https://practicaldermatology.com/news/score-droplette-micro-infuser-named-one-of-time-magazines-best-inventions-of-2022/2461427/Droplette’s Micro-Infuser Device is one